Becton, Dickinson and Co. | BDX - Ordinary Share Capital


Becton, Dickinson and Co. reported $284.91M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Agilent USD 282.7M 358K Dec/2025
Align Technology USD 71.75M 736K Dec/2025
AngioDynamics USD 41.57M 127K Sep/2025
Avanos Medical USD 46.46M 39.46K Dec/2025
Baxter International USD 514.28M 168.72M Dec/2025
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Bio-Rad Laboratories USD 26.97M 90K Sep/2025
Boston Scientific USD 1.48B 1.46B Jun/2025
Cooper Companies USD 195.1M 3.71M Dec/2025
Danaher USD 706.9M 600K Dec/2025
Dentsply International USD 199.5M 196.5M Sep/2025
Dexcom USD 384.8M 5.2M Dec/2025
Edwards Lifesciences USD 580.7M 7.2M Sep/2025
Globus Medical USD 135.06M 449K Dec/2025
Hologic USD 222.57M 350K Sep/2025
Insulet USD 70.35M 1000 Dec/2025
Integra LifeSciences USD 77.89M 34K Dec/2025
Intuitive Surgical USD 354.5M 3.98M Dec/2025
J&J USD 2.41B 584K Sep/2025
Masimo USD 52.1M 1000K Dec/2025
Medtronic USD 1.28B 1.38M Dec/2025
Solventum Corp USD 173.49M 51.34K Dec/2025
Stryker USD 382.4M 93K Dec/2025
Tandem Diabetes Care USD 68.29M 518K Dec/2025
Teleflex USD 44.19M 1000 Dec/2025
Terumo JPY 1.48B 0 Dec/2025
Thermo Fisher Scientific USD 375.71M 1.9M Dec/2025
Zimmer Biomet Holdings USD 198.18M 18.44K Dec/2025